07:06 PM EST, 11/13/2024 (MT Newswires) -- David P Schenkein, Director, on November 11, 2024, sold 59,441 shares in Denali Therapeutics ( DNLI ) for $1,932,665. Following the Form 4 filing with the SEC, Schenkein has control over a total of 66,684 shares of the company, with 9,220 shares held directly and 57,464 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1714899/000171489924000219/xslF345X05/wk-form4_1731532732.xml